Summary: Incannex Health care Inc furnished an update on its stage 2/3 trials of IHL-42X, its drug candidate becoming formulated for the procedure of obstructive rest apnea (OSA), detailing preparation throughout 25 US web sites with growth plans into Europe. This proprietary … [Read more...]